Department of Molecular Epidemiology, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.
The Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China.
Front Endocrinol (Lausanne). 2020 Apr 16;11:191. doi: 10.3389/fendo.2020.00191. eCollection 2020.
Metformin is a widely used biguanide drug due to its safety and low cost. It has been used for over 60 years to treat type 2 diabetes at the early stages because of its outstanding ability to decrease plasma glucose levels. Over time, different uses of metformin were discovered, and the benefits of metformin for various diseases and even aging were verified. These diseases include cancers (e.g., breast cancer, endometrial cancer, bone cancer, colorectal cancer, and melanoma), obesity, liver diseases, cardiovascular disease, and renal diseases. Metformin exerts different effects through different signaling pathways. However, the underlying mechanisms of these different benefits remain to be elucidated. The aim of this review is to provide a brief summary of the benefits of metformin and to discuss the possible underlying mechanisms.
二甲双胍是一种广泛应用的双胍类药物,由于其安全性和低成本,已被用于治疗 2 型糖尿病。它已经使用了 60 多年,因为它具有出色的降低血浆葡萄糖水平的能力。随着时间的推移,发现了二甲双胍的不同用途,并且证实了二甲双胍对各种疾病甚至衰老的益处。这些疾病包括癌症(如乳腺癌、子宫内膜癌、骨癌、结直肠癌和黑色素瘤)、肥胖症、肝脏疾病、心血管疾病和肾脏疾病。二甲双胍通过不同的信号通路发挥不同的作用。然而,这些不同益处的潜在机制仍有待阐明。本综述的目的是简要总结二甲双胍的益处,并讨论可能的潜在机制。